Global Long-acting Injectable Medications Market Research Report 2024(Status and Outlook)
Report Overview
Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdoses. Its origins in indications such as schizophrenia and contraception, also HIV treatment and prevention.
This report provides a deep insight into the global Long-acting Injectable Medications market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Long-acting Injectable Medications Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Long-acting Injectable Medications market in any manner.
Global Long-acting Injectable Medications Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eli Lilly
Alkermes
Johnson & Johnson
Zogenix
DURECT
Mapi Pharma
GSK
MedinCell
Oakwood Labs
Nanomi
Pharmathen
Kashiv BioSciences
Market Segmentation (by Type)
First-generation
Second-generation
Market Segmentation (by Application)
Schizophrenia
Contraception
HIV
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting Injectable Medications Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdoses. Its origins in indications such as schizophrenia and contraception, also HIV treatment and prevention.
This report provides a deep insight into the global Long-acting Injectable Medications market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Long-acting Injectable Medications Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Long-acting Injectable Medications market in any manner.
Global Long-acting Injectable Medications Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eli Lilly
Alkermes
Johnson & Johnson
Zogenix
DURECT
Mapi Pharma
GSK
MedinCell
Oakwood Labs
Nanomi
Pharmathen
Kashiv BioSciences
Market Segmentation (by Type)
First-generation
Second-generation
Market Segmentation (by Application)
Schizophrenia
Contraception
HIV
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Long-acting Injectable Medications Market
- Overview of the regional outlook of the Long-acting Injectable Medications Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting Injectable Medications Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Long-acting Injectable Medications
1.2 Key Market Segments
1.2.1 Long-acting Injectable Medications Segment by Type
1.2.2 Long-acting Injectable Medications Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG-ACTING INJECTABLE MEDICATIONS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long-acting Injectable Medications Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Long-acting Injectable Medications Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG-ACTING INJECTABLE MEDICATIONS MARKET COMPETITIVE LANDSCAPE
3.1 Global Long-acting Injectable Medications Sales by Manufacturers (2019-2024)
3.2 Global Long-acting Injectable Medications Revenue Market Share by Manufacturers (2019-2024)
3.3 Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Long-acting Injectable Medications Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Long-acting Injectable Medications Sales Sites, Area Served, Product Type
3.6 Long-acting Injectable Medications Market Competitive Situation and Trends
3.6.1 Long-acting Injectable Medications Market Concentration Rate
3.6.2 Global 5 and 10 Largest Long-acting Injectable Medications Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LONG-ACTING INJECTABLE MEDICATIONS INDUSTRY CHAIN ANALYSIS
4.1 Long-acting Injectable Medications Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG-ACTING INJECTABLE MEDICATIONS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LONG-ACTING INJECTABLE MEDICATIONS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting Injectable Medications Sales Market Share by Type (2019-2024)
6.3 Global Long-acting Injectable Medications Market Size Market Share by Type (2019-2024)
6.4 Global Long-acting Injectable Medications Price by Type (2019-2024)
7 LONG-ACTING INJECTABLE MEDICATIONS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting Injectable Medications Market Sales by Application (2019-2024)
7.3 Global Long-acting Injectable Medications Market Size (M USD) by Application (2019-2024)
7.4 Global Long-acting Injectable Medications Sales Growth Rate by Application (2019-2024)
8 LONG-ACTING INJECTABLE MEDICATIONS MARKET SEGMENTATION BY REGION
8.1 Global Long-acting Injectable Medications Sales by Region
8.1.1 Global Long-acting Injectable Medications Sales by Region
8.1.2 Global Long-acting Injectable Medications Sales Market Share by Region
8.2 North America
8.2.1 North America Long-acting Injectable Medications Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Long-acting Injectable Medications Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Long-acting Injectable Medications Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Long-acting Injectable Medications Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Long-acting Injectable Medications Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Eli Lilly
9.1.1 Eli Lilly Long-acting Injectable Medications Basic Information
9.1.2 Eli Lilly Long-acting Injectable Medications Product Overview
9.1.3 Eli Lilly Long-acting Injectable Medications Product Market Performance
9.1.4 Eli Lilly Business Overview
9.1.5 Eli Lilly Long-acting Injectable Medications SWOT Analysis
9.1.6 Eli Lilly Recent Developments
9.2 Alkermes
9.2.1 Alkermes Long-acting Injectable Medications Basic Information
9.2.2 Alkermes Long-acting Injectable Medications Product Overview
9.2.3 Alkermes Long-acting Injectable Medications Product Market Performance
9.2.4 Alkermes Business Overview
9.2.5 Alkermes Long-acting Injectable Medications SWOT Analysis
9.2.6 Alkermes Recent Developments
9.3 Johnson and Johnson
9.3.1 Johnson and Johnson Long-acting Injectable Medications Basic Information
9.3.2 Johnson and Johnson Long-acting Injectable Medications Product Overview
9.3.3 Johnson and Johnson Long-acting Injectable Medications Product Market Performance
9.3.4 Johnson and Johnson Long-acting Injectable Medications SWOT Analysis
9.3.5 Johnson and Johnson Business Overview
9.3.6 Johnson and Johnson Recent Developments
9.4 Zogenix
9.4.1 Zogenix Long-acting Injectable Medications Basic Information
9.4.2 Zogenix Long-acting Injectable Medications Product Overview
9.4.3 Zogenix Long-acting Injectable Medications Product Market Performance
9.4.4 Zogenix Business Overview
9.4.5 Zogenix Recent Developments
9.5 DURECT
9.5.1 DURECT Long-acting Injectable Medications Basic Information
9.5.2 DURECT Long-acting Injectable Medications Product Overview
9.5.3 DURECT Long-acting Injectable Medications Product Market Performance
9.5.4 DURECT Business Overview
9.5.5 DURECT Recent Developments
9.6 Mapi Pharma
9.6.1 Mapi Pharma Long-acting Injectable Medications Basic Information
9.6.2 Mapi Pharma Long-acting Injectable Medications Product Overview
9.6.3 Mapi Pharma Long-acting Injectable Medications Product Market Performance
9.6.4 Mapi Pharma Business Overview
9.6.5 Mapi Pharma Recent Developments
9.7 GSK
9.7.1 GSK Long-acting Injectable Medications Basic Information
9.7.2 GSK Long-acting Injectable Medications Product Overview
9.7.3 GSK Long-acting Injectable Medications Product Market Performance
9.7.4 GSK Business Overview
9.7.5 GSK Recent Developments
9.8 MedinCell
9.8.1 MedinCell Long-acting Injectable Medications Basic Information
9.8.2 MedinCell Long-acting Injectable Medications Product Overview
9.8.3 MedinCell Long-acting Injectable Medications Product Market Performance
9.8.4 MedinCell Business Overview
9.8.5 MedinCell Recent Developments
9.9 Oakwood Labs
9.9.1 Oakwood Labs Long-acting Injectable Medications Basic Information
9.9.2 Oakwood Labs Long-acting Injectable Medications Product Overview
9.9.3 Oakwood Labs Long-acting Injectable Medications Product Market Performance
9.9.4 Oakwood Labs Business Overview
9.9.5 Oakwood Labs Recent Developments
9.10 Nanomi
9.10.1 Nanomi Long-acting Injectable Medications Basic Information
9.10.2 Nanomi Long-acting Injectable Medications Product Overview
9.10.3 Nanomi Long-acting Injectable Medications Product Market Performance
9.10.4 Nanomi Business Overview
9.10.5 Nanomi Recent Developments
9.11 Pharmathen
9.11.1 Pharmathen Long-acting Injectable Medications Basic Information
9.11.2 Pharmathen Long-acting Injectable Medications Product Overview
9.11.3 Pharmathen Long-acting Injectable Medications Product Market Performance
9.11.4 Pharmathen Business Overview
9.11.5 Pharmathen Recent Developments
9.12 Kashiv BioSciences
9.12.1 Kashiv BioSciences Long-acting Injectable Medications Basic Information
9.12.2 Kashiv BioSciences Long-acting Injectable Medications Product Overview
9.12.3 Kashiv BioSciences Long-acting Injectable Medications Product Market Performance
9.12.4 Kashiv BioSciences Business Overview
9.12.5 Kashiv BioSciences Recent Developments
10 LONG-ACTING INJECTABLE MEDICATIONS MARKET FORECAST BY REGION
10.1 Global Long-acting Injectable Medications Market Size Forecast
10.2 Global Long-acting Injectable Medications Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Long-acting Injectable Medications Market Size Forecast by Country
10.2.3 Asia Pacific Long-acting Injectable Medications Market Size Forecast by Region
10.2.4 South America Long-acting Injectable Medications Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Long-acting Injectable Medications by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Long-acting Injectable Medications Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Long-acting Injectable Medications by Type (2025-2030)
11.1.2 Global Long-acting Injectable Medications Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Long-acting Injectable Medications by Type (2025-2030)
11.2 Global Long-acting Injectable Medications Market Forecast by Application (2025-2030)
11.2.1 Global Long-acting Injectable Medications Sales (K Units) Forecast by Application
11.2.2 Global Long-acting Injectable Medications Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Long-acting Injectable Medications
1.2 Key Market Segments
1.2.1 Long-acting Injectable Medications Segment by Type
1.2.2 Long-acting Injectable Medications Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG-ACTING INJECTABLE MEDICATIONS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long-acting Injectable Medications Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Long-acting Injectable Medications Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG-ACTING INJECTABLE MEDICATIONS MARKET COMPETITIVE LANDSCAPE
3.1 Global Long-acting Injectable Medications Sales by Manufacturers (2019-2024)
3.2 Global Long-acting Injectable Medications Revenue Market Share by Manufacturers (2019-2024)
3.3 Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Long-acting Injectable Medications Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Long-acting Injectable Medications Sales Sites, Area Served, Product Type
3.6 Long-acting Injectable Medications Market Competitive Situation and Trends
3.6.1 Long-acting Injectable Medications Market Concentration Rate
3.6.2 Global 5 and 10 Largest Long-acting Injectable Medications Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LONG-ACTING INJECTABLE MEDICATIONS INDUSTRY CHAIN ANALYSIS
4.1 Long-acting Injectable Medications Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG-ACTING INJECTABLE MEDICATIONS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LONG-ACTING INJECTABLE MEDICATIONS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting Injectable Medications Sales Market Share by Type (2019-2024)
6.3 Global Long-acting Injectable Medications Market Size Market Share by Type (2019-2024)
6.4 Global Long-acting Injectable Medications Price by Type (2019-2024)
7 LONG-ACTING INJECTABLE MEDICATIONS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting Injectable Medications Market Sales by Application (2019-2024)
7.3 Global Long-acting Injectable Medications Market Size (M USD) by Application (2019-2024)
7.4 Global Long-acting Injectable Medications Sales Growth Rate by Application (2019-2024)
8 LONG-ACTING INJECTABLE MEDICATIONS MARKET SEGMENTATION BY REGION
8.1 Global Long-acting Injectable Medications Sales by Region
8.1.1 Global Long-acting Injectable Medications Sales by Region
8.1.2 Global Long-acting Injectable Medications Sales Market Share by Region
8.2 North America
8.2.1 North America Long-acting Injectable Medications Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Long-acting Injectable Medications Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Long-acting Injectable Medications Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Long-acting Injectable Medications Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Long-acting Injectable Medications Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Eli Lilly
9.1.1 Eli Lilly Long-acting Injectable Medications Basic Information
9.1.2 Eli Lilly Long-acting Injectable Medications Product Overview
9.1.3 Eli Lilly Long-acting Injectable Medications Product Market Performance
9.1.4 Eli Lilly Business Overview
9.1.5 Eli Lilly Long-acting Injectable Medications SWOT Analysis
9.1.6 Eli Lilly Recent Developments
9.2 Alkermes
9.2.1 Alkermes Long-acting Injectable Medications Basic Information
9.2.2 Alkermes Long-acting Injectable Medications Product Overview
9.2.3 Alkermes Long-acting Injectable Medications Product Market Performance
9.2.4 Alkermes Business Overview
9.2.5 Alkermes Long-acting Injectable Medications SWOT Analysis
9.2.6 Alkermes Recent Developments
9.3 Johnson and Johnson
9.3.1 Johnson and Johnson Long-acting Injectable Medications Basic Information
9.3.2 Johnson and Johnson Long-acting Injectable Medications Product Overview
9.3.3 Johnson and Johnson Long-acting Injectable Medications Product Market Performance
9.3.4 Johnson and Johnson Long-acting Injectable Medications SWOT Analysis
9.3.5 Johnson and Johnson Business Overview
9.3.6 Johnson and Johnson Recent Developments
9.4 Zogenix
9.4.1 Zogenix Long-acting Injectable Medications Basic Information
9.4.2 Zogenix Long-acting Injectable Medications Product Overview
9.4.3 Zogenix Long-acting Injectable Medications Product Market Performance
9.4.4 Zogenix Business Overview
9.4.5 Zogenix Recent Developments
9.5 DURECT
9.5.1 DURECT Long-acting Injectable Medications Basic Information
9.5.2 DURECT Long-acting Injectable Medications Product Overview
9.5.3 DURECT Long-acting Injectable Medications Product Market Performance
9.5.4 DURECT Business Overview
9.5.5 DURECT Recent Developments
9.6 Mapi Pharma
9.6.1 Mapi Pharma Long-acting Injectable Medications Basic Information
9.6.2 Mapi Pharma Long-acting Injectable Medications Product Overview
9.6.3 Mapi Pharma Long-acting Injectable Medications Product Market Performance
9.6.4 Mapi Pharma Business Overview
9.6.5 Mapi Pharma Recent Developments
9.7 GSK
9.7.1 GSK Long-acting Injectable Medications Basic Information
9.7.2 GSK Long-acting Injectable Medications Product Overview
9.7.3 GSK Long-acting Injectable Medications Product Market Performance
9.7.4 GSK Business Overview
9.7.5 GSK Recent Developments
9.8 MedinCell
9.8.1 MedinCell Long-acting Injectable Medications Basic Information
9.8.2 MedinCell Long-acting Injectable Medications Product Overview
9.8.3 MedinCell Long-acting Injectable Medications Product Market Performance
9.8.4 MedinCell Business Overview
9.8.5 MedinCell Recent Developments
9.9 Oakwood Labs
9.9.1 Oakwood Labs Long-acting Injectable Medications Basic Information
9.9.2 Oakwood Labs Long-acting Injectable Medications Product Overview
9.9.3 Oakwood Labs Long-acting Injectable Medications Product Market Performance
9.9.4 Oakwood Labs Business Overview
9.9.5 Oakwood Labs Recent Developments
9.10 Nanomi
9.10.1 Nanomi Long-acting Injectable Medications Basic Information
9.10.2 Nanomi Long-acting Injectable Medications Product Overview
9.10.3 Nanomi Long-acting Injectable Medications Product Market Performance
9.10.4 Nanomi Business Overview
9.10.5 Nanomi Recent Developments
9.11 Pharmathen
9.11.1 Pharmathen Long-acting Injectable Medications Basic Information
9.11.2 Pharmathen Long-acting Injectable Medications Product Overview
9.11.3 Pharmathen Long-acting Injectable Medications Product Market Performance
9.11.4 Pharmathen Business Overview
9.11.5 Pharmathen Recent Developments
9.12 Kashiv BioSciences
9.12.1 Kashiv BioSciences Long-acting Injectable Medications Basic Information
9.12.2 Kashiv BioSciences Long-acting Injectable Medications Product Overview
9.12.3 Kashiv BioSciences Long-acting Injectable Medications Product Market Performance
9.12.4 Kashiv BioSciences Business Overview
9.12.5 Kashiv BioSciences Recent Developments
10 LONG-ACTING INJECTABLE MEDICATIONS MARKET FORECAST BY REGION
10.1 Global Long-acting Injectable Medications Market Size Forecast
10.2 Global Long-acting Injectable Medications Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Long-acting Injectable Medications Market Size Forecast by Country
10.2.3 Asia Pacific Long-acting Injectable Medications Market Size Forecast by Region
10.2.4 South America Long-acting Injectable Medications Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Long-acting Injectable Medications by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Long-acting Injectable Medications Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Long-acting Injectable Medications by Type (2025-2030)
11.1.2 Global Long-acting Injectable Medications Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Long-acting Injectable Medications by Type (2025-2030)
11.2 Global Long-acting Injectable Medications Market Forecast by Application (2025-2030)
11.2.1 Global Long-acting Injectable Medications Sales (K Units) Forecast by Application
11.2.2 Global Long-acting Injectable Medications Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Long-acting Injectable Medications Market Size Comparison by Region (M USD)
Table 5. Global Long-acting Injectable Medications Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Long-acting Injectable Medications Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Long-acting Injectable Medications Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Long-acting Injectable Medications Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Injectable Medications as of 2022)
Table 10. Global Market Long-acting Injectable Medications Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Long-acting Injectable Medications Sales Sites and Area Served
Table 12. Manufacturers Long-acting Injectable Medications Product Type
Table 13. Global Long-acting Injectable Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Long-acting Injectable Medications
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long-acting Injectable Medications Market Challenges
Table 22. Global Long-acting Injectable Medications Sales by Type (K Units)
Table 23. Global Long-acting Injectable Medications Market Size by Type (M USD)
Table 24. Global Long-acting Injectable Medications Sales (K Units) by Type (2019-2024)
Table 25. Global Long-acting Injectable Medications Sales Market Share by Type (2019-2024)
Table 26. Global Long-acting Injectable Medications Market Size (M USD) by Type (2019-2024)
Table 27. Global Long-acting Injectable Medications Market Size Share by Type (2019-2024)
Table 28. Global Long-acting Injectable Medications Price (USD/Unit) by Type (2019-2024)
Table 29. Global Long-acting Injectable Medications Sales (K Units) by Application
Table 30. Global Long-acting Injectable Medications Market Size by Application
Table 31. Global Long-acting Injectable Medications Sales by Application (2019-2024) & (K Units)
Table 32. Global Long-acting Injectable Medications Sales Market Share by Application (2019-2024)
Table 33. Global Long-acting Injectable Medications Sales by Application (2019-2024) & (M USD)
Table 34. Global Long-acting Injectable Medications Market Share by Application (2019-2024)
Table 35. Global Long-acting Injectable Medications Sales Growth Rate by Application (2019-2024)
Table 36. Global Long-acting Injectable Medications Sales by Region (2019-2024) & (K Units)
Table 37. Global Long-acting Injectable Medications Sales Market Share by Region (2019-2024)
Table 38. North America Long-acting Injectable Medications Sales by Country (2019-2024) & (K Units)
Table 39. Europe Long-acting Injectable Medications Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Long-acting Injectable Medications Sales by Region (2019-2024) & (K Units)
Table 41. South America Long-acting Injectable Medications Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Long-acting Injectable Medications Sales by Region (2019-2024) & (K Units)
Table 43. Eli Lilly Long-acting Injectable Medications Basic Information
Table 44. Eli Lilly Long-acting Injectable Medications Product Overview
Table 45. Eli Lilly Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Eli Lilly Business Overview
Table 47. Eli Lilly Long-acting Injectable Medications SWOT Analysis
Table 48. Eli Lilly Recent Developments
Table 49. Alkermes Long-acting Injectable Medications Basic Information
Table 50. Alkermes Long-acting Injectable Medications Product Overview
Table 51. Alkermes Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Alkermes Business Overview
Table 53. Alkermes Long-acting Injectable Medications SWOT Analysis
Table 54. Alkermes Recent Developments
Table 55. Johnson and Johnson Long-acting Injectable Medications Basic Information
Table 56. Johnson and Johnson Long-acting Injectable Medications Product Overview
Table 57. Johnson and Johnson Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Johnson and Johnson Long-acting Injectable Medications SWOT Analysis
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Recent Developments
Table 61. Zogenix Long-acting Injectable Medications Basic Information
Table 62. Zogenix Long-acting Injectable Medications Product Overview
Table 63. Zogenix Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Zogenix Business Overview
Table 65. Zogenix Recent Developments
Table 66. DURECT Long-acting Injectable Medications Basic Information
Table 67. DURECT Long-acting Injectable Medications Product Overview
Table 68. DURECT Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. DURECT Business Overview
Table 70. DURECT Recent Developments
Table 71. Mapi Pharma Long-acting Injectable Medications Basic Information
Table 72. Mapi Pharma Long-acting Injectable Medications Product Overview
Table 73. Mapi Pharma Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Mapi Pharma Business Overview
Table 75. Mapi Pharma Recent Developments
Table 76. GSK Long-acting Injectable Medications Basic Information
Table 77. GSK Long-acting Injectable Medications Product Overview
Table 78. GSK Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. GSK Business Overview
Table 80. GSK Recent Developments
Table 81. MedinCell Long-acting Injectable Medications Basic Information
Table 82. MedinCell Long-acting Injectable Medications Product Overview
Table 83. MedinCell Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. MedinCell Business Overview
Table 85. MedinCell Recent Developments
Table 86. Oakwood Labs Long-acting Injectable Medications Basic Information
Table 87. Oakwood Labs Long-acting Injectable Medications Product Overview
Table 88. Oakwood Labs Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Oakwood Labs Business Overview
Table 90. Oakwood Labs Recent Developments
Table 91. Nanomi Long-acting Injectable Medications Basic Information
Table 92. Nanomi Long-acting Injectable Medications Product Overview
Table 93. Nanomi Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Nanomi Business Overview
Table 95. Nanomi Recent Developments
Table 96. Pharmathen Long-acting Injectable Medications Basic Information
Table 97. Pharmathen Long-acting Injectable Medications Product Overview
Table 98. Pharmathen Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pharmathen Business Overview
Table 100. Pharmathen Recent Developments
Table 101. Kashiv BioSciences Long-acting Injectable Medications Basic Information
Table 102. Kashiv BioSciences Long-acting Injectable Medications Product Overview
Table 103. Kashiv BioSciences Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Kashiv BioSciences Business Overview
Table 105. Kashiv BioSciences Recent Developments
Table 106. Global Long-acting Injectable Medications Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Long-acting Injectable Medications Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Long-acting Injectable Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Long-acting Injectable Medications Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Long-acting Injectable Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Long-acting Injectable Medications Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Long-acting Injectable Medications Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Long-acting Injectable Medications Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Long-acting Injectable Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Long-acting Injectable Medications Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Long-acting Injectable Medications Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Long-acting Injectable Medications Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Long-acting Injectable Medications Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Long-acting Injectable Medications Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Long-acting Injectable Medications Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Long-acting Injectable Medications Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Long-acting Injectable Medications Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Long-acting Injectable Medications Market Size Comparison by Region (M USD)
Table 5. Global Long-acting Injectable Medications Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Long-acting Injectable Medications Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Long-acting Injectable Medications Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Long-acting Injectable Medications Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Injectable Medications as of 2022)
Table 10. Global Market Long-acting Injectable Medications Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Long-acting Injectable Medications Sales Sites and Area Served
Table 12. Manufacturers Long-acting Injectable Medications Product Type
Table 13. Global Long-acting Injectable Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Long-acting Injectable Medications
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long-acting Injectable Medications Market Challenges
Table 22. Global Long-acting Injectable Medications Sales by Type (K Units)
Table 23. Global Long-acting Injectable Medications Market Size by Type (M USD)
Table 24. Global Long-acting Injectable Medications Sales (K Units) by Type (2019-2024)
Table 25. Global Long-acting Injectable Medications Sales Market Share by Type (2019-2024)
Table 26. Global Long-acting Injectable Medications Market Size (M USD) by Type (2019-2024)
Table 27. Global Long-acting Injectable Medications Market Size Share by Type (2019-2024)
Table 28. Global Long-acting Injectable Medications Price (USD/Unit) by Type (2019-2024)
Table 29. Global Long-acting Injectable Medications Sales (K Units) by Application
Table 30. Global Long-acting Injectable Medications Market Size by Application
Table 31. Global Long-acting Injectable Medications Sales by Application (2019-2024) & (K Units)
Table 32. Global Long-acting Injectable Medications Sales Market Share by Application (2019-2024)
Table 33. Global Long-acting Injectable Medications Sales by Application (2019-2024) & (M USD)
Table 34. Global Long-acting Injectable Medications Market Share by Application (2019-2024)
Table 35. Global Long-acting Injectable Medications Sales Growth Rate by Application (2019-2024)
Table 36. Global Long-acting Injectable Medications Sales by Region (2019-2024) & (K Units)
Table 37. Global Long-acting Injectable Medications Sales Market Share by Region (2019-2024)
Table 38. North America Long-acting Injectable Medications Sales by Country (2019-2024) & (K Units)
Table 39. Europe Long-acting Injectable Medications Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Long-acting Injectable Medications Sales by Region (2019-2024) & (K Units)
Table 41. South America Long-acting Injectable Medications Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Long-acting Injectable Medications Sales by Region (2019-2024) & (K Units)
Table 43. Eli Lilly Long-acting Injectable Medications Basic Information
Table 44. Eli Lilly Long-acting Injectable Medications Product Overview
Table 45. Eli Lilly Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Eli Lilly Business Overview
Table 47. Eli Lilly Long-acting Injectable Medications SWOT Analysis
Table 48. Eli Lilly Recent Developments
Table 49. Alkermes Long-acting Injectable Medications Basic Information
Table 50. Alkermes Long-acting Injectable Medications Product Overview
Table 51. Alkermes Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Alkermes Business Overview
Table 53. Alkermes Long-acting Injectable Medications SWOT Analysis
Table 54. Alkermes Recent Developments
Table 55. Johnson and Johnson Long-acting Injectable Medications Basic Information
Table 56. Johnson and Johnson Long-acting Injectable Medications Product Overview
Table 57. Johnson and Johnson Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Johnson and Johnson Long-acting Injectable Medications SWOT Analysis
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Recent Developments
Table 61. Zogenix Long-acting Injectable Medications Basic Information
Table 62. Zogenix Long-acting Injectable Medications Product Overview
Table 63. Zogenix Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Zogenix Business Overview
Table 65. Zogenix Recent Developments
Table 66. DURECT Long-acting Injectable Medications Basic Information
Table 67. DURECT Long-acting Injectable Medications Product Overview
Table 68. DURECT Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. DURECT Business Overview
Table 70. DURECT Recent Developments
Table 71. Mapi Pharma Long-acting Injectable Medications Basic Information
Table 72. Mapi Pharma Long-acting Injectable Medications Product Overview
Table 73. Mapi Pharma Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Mapi Pharma Business Overview
Table 75. Mapi Pharma Recent Developments
Table 76. GSK Long-acting Injectable Medications Basic Information
Table 77. GSK Long-acting Injectable Medications Product Overview
Table 78. GSK Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. GSK Business Overview
Table 80. GSK Recent Developments
Table 81. MedinCell Long-acting Injectable Medications Basic Information
Table 82. MedinCell Long-acting Injectable Medications Product Overview
Table 83. MedinCell Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. MedinCell Business Overview
Table 85. MedinCell Recent Developments
Table 86. Oakwood Labs Long-acting Injectable Medications Basic Information
Table 87. Oakwood Labs Long-acting Injectable Medications Product Overview
Table 88. Oakwood Labs Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Oakwood Labs Business Overview
Table 90. Oakwood Labs Recent Developments
Table 91. Nanomi Long-acting Injectable Medications Basic Information
Table 92. Nanomi Long-acting Injectable Medications Product Overview
Table 93. Nanomi Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Nanomi Business Overview
Table 95. Nanomi Recent Developments
Table 96. Pharmathen Long-acting Injectable Medications Basic Information
Table 97. Pharmathen Long-acting Injectable Medications Product Overview
Table 98. Pharmathen Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pharmathen Business Overview
Table 100. Pharmathen Recent Developments
Table 101. Kashiv BioSciences Long-acting Injectable Medications Basic Information
Table 102. Kashiv BioSciences Long-acting Injectable Medications Product Overview
Table 103. Kashiv BioSciences Long-acting Injectable Medications Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Kashiv BioSciences Business Overview
Table 105. Kashiv BioSciences Recent Developments
Table 106. Global Long-acting Injectable Medications Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Long-acting Injectable Medications Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Long-acting Injectable Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Long-acting Injectable Medications Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Long-acting Injectable Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Long-acting Injectable Medications Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Long-acting Injectable Medications Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Long-acting Injectable Medications Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Long-acting Injectable Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Long-acting Injectable Medications Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Long-acting Injectable Medications Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Long-acting Injectable Medications Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Long-acting Injectable Medications Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Long-acting Injectable Medications Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Long-acting Injectable Medications Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Long-acting Injectable Medications Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Long-acting Injectable Medications Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Long-acting Injectable Medications
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting Injectable Medications Market Size (M USD), 2019-2030
Figure 5. Global Long-acting Injectable Medications Market Size (M USD) (2019-2030)
Figure 6. Global Long-acting Injectable Medications Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting Injectable Medications Market Size by Country (M USD)
Figure 11. Long-acting Injectable Medications Sales Share by Manufacturers in 2023
Figure 12. Global Long-acting Injectable Medications Revenue Share by Manufacturers in 2023
Figure 13. Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Long-acting Injectable Medications Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Long-acting Injectable Medications Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Long-acting Injectable Medications Market Share by Type
Figure 18. Sales Market Share of Long-acting Injectable Medications by Type (2019-2024)
Figure 19. Sales Market Share of Long-acting Injectable Medications by Type in 2023
Figure 20. Market Size Share of Long-acting Injectable Medications by Type (2019-2024)
Figure 21. Market Size Market Share of Long-acting Injectable Medications by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Long-acting Injectable Medications Market Share by Application
Figure 24. Global Long-acting Injectable Medications Sales Market Share by Application (2019-2024)
Figure 25. Global Long-acting Injectable Medications Sales Market Share by Application in 2023
Figure 26. Global Long-acting Injectable Medications Market Share by Application (2019-2024)
Figure 27. Global Long-acting Injectable Medications Market Share by Application in 2023
Figure 28. Global Long-acting Injectable Medications Sales Growth Rate by Application (2019-2024)
Figure 29. Global Long-acting Injectable Medications Sales Market Share by Region (2019-2024)
Figure 30. North America Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Long-acting Injectable Medications Sales Market Share by Country in 2023
Figure 32. U.S. Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Long-acting Injectable Medications Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Long-acting Injectable Medications Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Long-acting Injectable Medications Sales Market Share by Country in 2023
Figure 37. Germany Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Long-acting Injectable Medications Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Long-acting Injectable Medications Sales Market Share by Region in 2023
Figure 44. China Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Long-acting Injectable Medications Sales and Growth Rate (K Units)
Figure 50. South America Long-acting Injectable Medications Sales Market Share by Country in 2023
Figure 51. Brazil Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Long-acting Injectable Medications Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Long-acting Injectable Medications Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Long-acting Injectable Medications Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Long-acting Injectable Medications Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Long-acting Injectable Medications Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Long-acting Injectable Medications Market Share Forecast by Type (2025-2030)
Figure 65. Global Long-acting Injectable Medications Sales Forecast by Application (2025-2030)
Figure 66. Global Long-acting Injectable Medications Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Long-acting Injectable Medications
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting Injectable Medications Market Size (M USD), 2019-2030
Figure 5. Global Long-acting Injectable Medications Market Size (M USD) (2019-2030)
Figure 6. Global Long-acting Injectable Medications Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting Injectable Medications Market Size by Country (M USD)
Figure 11. Long-acting Injectable Medications Sales Share by Manufacturers in 2023
Figure 12. Global Long-acting Injectable Medications Revenue Share by Manufacturers in 2023
Figure 13. Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Long-acting Injectable Medications Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Long-acting Injectable Medications Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Long-acting Injectable Medications Market Share by Type
Figure 18. Sales Market Share of Long-acting Injectable Medications by Type (2019-2024)
Figure 19. Sales Market Share of Long-acting Injectable Medications by Type in 2023
Figure 20. Market Size Share of Long-acting Injectable Medications by Type (2019-2024)
Figure 21. Market Size Market Share of Long-acting Injectable Medications by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Long-acting Injectable Medications Market Share by Application
Figure 24. Global Long-acting Injectable Medications Sales Market Share by Application (2019-2024)
Figure 25. Global Long-acting Injectable Medications Sales Market Share by Application in 2023
Figure 26. Global Long-acting Injectable Medications Market Share by Application (2019-2024)
Figure 27. Global Long-acting Injectable Medications Market Share by Application in 2023
Figure 28. Global Long-acting Injectable Medications Sales Growth Rate by Application (2019-2024)
Figure 29. Global Long-acting Injectable Medications Sales Market Share by Region (2019-2024)
Figure 30. North America Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Long-acting Injectable Medications Sales Market Share by Country in 2023
Figure 32. U.S. Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Long-acting Injectable Medications Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Long-acting Injectable Medications Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Long-acting Injectable Medications Sales Market Share by Country in 2023
Figure 37. Germany Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Long-acting Injectable Medications Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Long-acting Injectable Medications Sales Market Share by Region in 2023
Figure 44. China Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Long-acting Injectable Medications Sales and Growth Rate (K Units)
Figure 50. South America Long-acting Injectable Medications Sales Market Share by Country in 2023
Figure 51. Brazil Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Long-acting Injectable Medications Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Long-acting Injectable Medications Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Long-acting Injectable Medications Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Long-acting Injectable Medications Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Long-acting Injectable Medications Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Long-acting Injectable Medications Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Long-acting Injectable Medications Market Share Forecast by Type (2025-2030)
Figure 65. Global Long-acting Injectable Medications Sales Forecast by Application (2025-2030)
Figure 66. Global Long-acting Injectable Medications Market Share Forecast by Application (2025-2030)
